ImmuneSpec employee Elisa will help shape the scientific strategy, strengthen data analysis and bioinformatics approaches, support team development, and work directly with clients across immunology and translational projects.
Public source
Publisher name
Public post
๐๐บ๐บ๐๐ป๐ฒ๐ฆ๐ฝ๐ฒ๐ฐ ๐ถ๐ ๐๐๐ฟ๐ฒ๐ป๐ด๐๐ต๐ฒ๐ป๐ถ๐ป๐ด ๐ถ๐๐ ๐๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐น๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐๐ต๐ถ๐ฝ. ๐๐ฟ. ๐๐น๐ถ๐๐ฎ ๐ฅ๐ผ๐๐ฎ๐๐ถ ๐ฆ๐ฐ๐ฎ๐น๐ฐ๐ต๐ถ ๐ต๐ฎ๐ ๐ท๐ผ๐ถ๐ป๐ฒ๐ฑ ๏ฟฝโฆ
Company
ImmuneSpec
Excellence in immunopeptidomics for better, safer biotherapeutics.
- Industry
- Biotechnology Research
- Location
- Niel, BE
- Company size
- 11โ50 employees
About ImmuneSpec
ImmuneSpec is a next-generation immunopeptidomics platform that delivers unmatched precision in identifying peptides presented by MHC molecules. Powered by advanced mass spectrometry, ImmuneSpec provides deep, unbiased insight into immune presentationโenabling the development of safer, more effective biotherapeutics. The platform supports early detection of immunogenic regions in biologics, reducing immune risk and guiding safer drug design. ImmuneSpec also accelerates target discovery by revealing rare neoepitopes and validates constructs by confirming that designed epitopes are effectively presented. With rapid turnaround, high-throughput capability, and rigorous quality control, ImmuneSpec empowers researchers to advance transformative therapiesโfrom personalized medicine to next-generation vaccines and immunotherapies.
See moreLatest activity
Latest activity from ImmuneSpec
2 signals
Discover more
Similar signals
Similar public activity from other companies.
People
CytoHub Inc.
CytoHub Inc. hired Rista White as a Research Associate I.
People
Annogen
Annogen employee Ludo Pagie has been part of the company for five years and leads the bioinformatics team with data analysis, pipeline development, and systems.
People
Switchpoint Bio
Switchpoint Bio appointed Jason as its scientific co-founder.
People
Ingenza Ltd
Ingenza Ltd employee Heather Currie is a Team Leader within DSP & Assay Development and works on vaccine and therapeutic peptide development.
People
Cabaletta Bio